Wolverine Trading
ADMA icon

Wolverine Trading’s ADMA Biologics ADMA Stock Holding History

Wolverine Trading’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.82M Buy
+123,900
New +$2.12M ﹤0.01% 2262
2025
Q2 		– Sell
-48,900
Closed -$991K – 4550
2025
Q1 		$991K Buy
+48,900
New +$846K ﹤0.01% 2240

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wolverine Trading's ADMA Position: Q3 2025 in Review

Wolverine Trading opened a new position in ADMA Biologics (ADMA) in Q3 2025: 20,272 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #4391 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in ADMA as recently as Q1 2025.

Wolverine Trading first reported a position in ADMA in Q1 2025 and has held it in 2 quarters since. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Wolverine Trading held 20,272 shares of ADMA Biologics worth $298K as of Q3 2025.
  • ADMA Biologics was a new Wolverine Trading position in Q3 2025.
  • ADMA Biologics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4391 holding.
  • Wolverine Trading first reported a position in ADMA Biologics in Q1 2025 and has held it in 2 quarters since.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.